Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Meningococcal, influenza virus, and hepatitis B virus vaccination coverage level among health care workers in Hajj

BMC Infectious Diseases20077:80

DOI: 10.1186/1471-2334-7-80

Received: 03 January 2007

Accepted: 18 July 2007

Published: 18 July 2007

Abstract

Background

The objective of this study was to assess the compliance of health care workers (HCWs) employed in Hajj in receiving the meningococcal, influenza, and hepatitis B vaccines.

Methods

A cross-sectional survey of doctors and nurses working in all Mena and Arafat hospitals and primary health care centers who attended Hajj-medicine training programs immediately before the beginning of Hajj of the lunar Islamic year 1423 (2003) using self-administered structured questionnaire which included demographic data and data on vaccination history.

Results

A total of 392 HCWs were studied including 215 (54.8%) nurses and 177 (45.2%) doctors. One hundred and sixty four (41.8%) HCWs were from Makkah and the rest were recruited from other regions in Saudi Arabia. Three hundred and twenty three (82.4%) HCWs received the quadrivalent (ACYW135) meningococcal meningitis vaccine with 271 (83.9%) HCWs receiving it at least 2 weeks before coming to Hajj, whereas the remaining 52 (16.1%) HCWs received it within < 2 weeks. Only 23 (5.9%) HCWs received the current year's influenza virus vaccine. Two hundred and sixty (66.3%) of HCWs received the three-dose hepatitis B vaccine series, 19.3% received one or two doses, and 14.3% did not receive any dose. There was no statistically significant difference in compliance with the three vaccines between doctors and nurses.

Conclusion

The meningococcal and hepatitis B vaccination coverage level among HCWs in Hajj was suboptimal and the influenza vaccination level was notably low. Strategies to improve vaccination coverage among HCWs should be adopted by all health care facilities in Saudi Arabia.

Background

Ensuring that health care workers (HCWs) are immune to vaccine-preventable diseases is an essential part of successful employee health programs. Optimal use of vaccines can prevent transmission of vaccine-preventable diseases and eliminate unnecessary work restriction. Prevention of illness through comprehensive HCWs immunization programs is far more cost-effective than case management and outbreak control [1]. In Saudi Arabia, the national vaccination recommendations for HCWs are generally the same as those recommended by the Centers for Disease Control and Prevention [2]. Meningococcal vaccination of all HCWs is additionally recommended in Saudi Arabia, particularly for those working directly with pilgrims in Hajj. Influenza and hepatitis B vaccines are also emphasized for this group of HCWs. These three and other required vaccines are made available free of charge for all HCWs in all health care facilities in Saudi Arabia. The objective of this study was to assess the compliance of HCWs employed in Hajj in receiving the meningococcal, influenza, and hepatitis B vaccines that are particularly recommended for Hajj by the Ministry of Health.

Methods

Hajj

Hajj is the fifth of the five pillars of Islam. Any healthy Muslim adult is required to perform Hajj once in his/her life if he/she is financially and physically capable. The Hajj begins on the 8th day of Dhul-Hijjah, the 12th month of the lunar Islamic year, and ends on the 13th day of the same month. Hajj has to be performed in three main locations in Makkah, namely, the sacred Kaaba (in the holy city of Makkah), and Mena and Arafat, which are approximately 5 and 18 Kilometers far from Makkah, respectively. Approximately, 2–3 million pilgrims perform Hajj every year; one third of whom come from within Saudi Arabia and two thirds come from other countries. Most pilgrims stay in fire-resistant air-conditioned camping tents in Mena during the entire Hajj period. Financially deprived pilgrims who cannot afford to pay for the cost of staying in camps usually stay outdoor. Free medical care services are provided to pilgrims by the Saudi Ministry of Health.

Study design and population

A cross-sectional survey was conducted in Mena and Arafat during the Hajj season of the Islamic year 1423 corresponding to 2003 Gregorian. HCWs included in the study were all doctors and nurses working in Mena and Arafat hospitals and primary health care centers who attended Hajj-medicine training programs immediately before the beginning of Hajj. Many of the HCWs were recruited from various regions in Saudi Arabia to supplement the local HCWs working in Makkah to cover the extensive medical services provided to pilgrims in Hajj.

Data collection

The Saudi Ministry of Health approved the study. Data were collected using a structured questionnaire which included demographic data and data on vaccination history. The questionnaire was anonymously self-administered by HCWs with supervision from the research team members.

Data analysis

Data entry and statistical analysis were performed using computer and the Statistical Package for Social Science (SPSS) program. Descriptive statistics, cross tabulations, and Chi-square test were performed as appropriate. Multiple logistic regression analysis was performed to identify predictors of compliance to vaccination after controlling for possible confounding factors. Statistical significance was set at < 0.05.

Results

A total of 392 HCWs attended the Hajj-medicine training programs. All HCWs agreed to participate in the study with 100% response rate. Two hundred and fifteen (54.8%) HCWs were nurses and 177 (45.2%) HCWs were doctors. Three hundred and fifteen (80.4%) HCWs worked in hospitals, whereas 77 (19.6%) HCWs worked in primary health care centers during this Hajj season. Of the 392 HCWs, 164 (41.8%) HCWs were from Makkah, 85 (21.8%), from Riyadh, 53 (13.6%), from the Eastern Region, 28 (7.3%), from Asir, 21 (5.3%), from Al-Qassim, 13 (3.4%), from Najran, 8 (1.9%), each from Al-Baha and Jizan, and 4 (1.0%), each from Al-Jouf, Hail, and Northern Region.

Table 1 shows the socio-demographic characteristics of HCWs included in the study. Of the 392 HCWs, 323 (82.4%) HCWs received the quadrivalent (ACYW135) meningococcal vaccine recommended by the Ministry of Health. There was no statistically significant difference in compliance with this vaccine between doctors and nurses (78.9% versus 85.4%, respectively, p = 0.172). Of the 323 (82.4%) HCWs who received the meningococcal vaccine, 271 (83.9%) HCWs received it at least 2 weeks and not more than 3 years before coming to Hajj as recommended by the Ministry of Health, whereas the remaining 52 (16.1%) HCWs received it within less than 2 weeks.
Table 1

Socio-demographic characteristics of 177 doctors and 215 nurses included in the study

Characteristic

Number

Percent

Sex:

  

   Doctors:

  

Male

142

80.2

Female

35

19.8

   Nurses:

  

Male

49

22.8

Female

166

77.2

Age group (year)

  

   Doctors

  

20–30

7

4.0

31–40

71

40.1

41–50

79

44.6

51–60

20

11.3

   Nurses

  

20–30

100

46.5

31–40

69

32.1

41–50

33

15.3

51–60

13

6.1

Nationality:

  

   Doctors:

  

Saudi

46

26.0

Non-Saudi

131

74.0

   Nurses:

  

Saudi

62

28.8

Non-Saudi

153

71.2

Years of experience

  

   Doctors

  

1–10

68

38.4

11–20

85

48.0

21 or more

24

13.6

   Nurses

  

1–10

115

53.5

11–20

78

36.3

21 or more

22

10.2

Degree:

  

   Doctors:

  

Bachelor

52

29.4

Master/Diploma

72

40.7

Doctorate/Board

53

29.9

   Nurses:

  

Diploma

137

63.7

Bachelor

78

36.3

Position

  

   Doctors:

  

General Practitioner

30

16.9

Resident

57

32.2

Specialist

69

39.0

Consultant

21

11.9

   Nurses

  

Staff nurse

192

89.3

Head nurse

23

10.7

Original work place

  

   Makkah

164

41.8

   Riyadh

85

21.8

   North region

4

1.0

   Eastern region

53

13.6

   Jazan

8

1.9

   Asir

28

7.3

   Najran

13

3.4

   Baha

8

1.9

   Qaseem

21

5.3

   Aljouf

4

1.0

   Hail

4

1.0

Only 23 (5.9%) HCWs received the current year's influenza virus vaccine. There was no statistically significant difference in compliance with this vaccine between doctors and nurses (5.6 % versus 7.4 %, respectively, p = 0.573).

Of the 392 HCWs, 260 (66.3%) HCWs completed the three-dose series of the hepatitis B vaccine, 48 (12.2%) HCWs received 2 doses, 28 (7.1%) HCWs received one dose, and 56 (14.3 %) HCWs did not receive any dose of the vaccine. There was no statistically significant difference in compliance with hepatitis B vaccination between doctors and nurses (Table 2). Of the 260 HCWs who completed the hepatitis B vaccination series, 134 (51.5%) HCWs had post-vaccination tests to confirm development of immunity.
Table 2

Compliance of 392 health care workers (177 doctors and 215 nurses) with the hepatitis B virus vaccination

Number of doses

Overall %

% of doctors

% of nurses

None

14.3

14.4

14.1

1 dose

7.1

7.2

6.8

2 doses

12.2

16.2

9.2

3 or more doses

66.3

62.3

69.9

X2 df = 6 = 11.25, p-value = 0.081.

Table 3 shows a bivariate analysis of the compliance of 392 health care workers for receiving the quadrivalent meningococcal meningitis, influenza, and hepatitis B vaccines according to their gender, age group, nationality, years of experience, degree, position, and original place of work. This analysis showed no statistically significant difference in compliance with the receipt of the vaccines among the various groups with two exceptions; the compliance of non-Saudi HCWs for the receipt of the meningitis vaccine was significantly higher than that of the Saudi mates (84.2% versus 77.8%, p = 0.027), and the compliance of HCWs with lower degrees (diploma and bachelor) was significantly higher than that of HCWs with higher degrees (p = 0.011). Multivariate logistic regression analysis confirmed that non-Saudi nationality was an independent predictor of a better compliance with the meningitis vaccine (odds ratio = 3.28, 95% confidence interval = 1.17 – 9.21, p = 0.024). However, lower degrees were not independent predictors of a better compliance with this vaccine (p = 0.797).
Table 3

Bivariate analysis of the compliance of 392 health care workers (HCWs) for receiving the ACYW135 meningococcal meningitis, influenza, and at least one dose of the hepatitis B vaccines according to their gender, age group, nationality, years of experience, degree, position, and original place of work.

 

Number of HCWs

HCWs who received the meningococcal vaccine (%)

P

HCWs who received the influenza vaccine (%)

P

HCWs who received at least one dose of the hepatitis B vaccine (%)

P

Total number of HCWs

392

323 (82.4)

 

23 (5.9)

 

336 (85.7)

 

Sex

       

   Male

191

150 (78.5)

0.327

9 (4.7)

0.319

157 (82.2)

0.567

   Female

201

173 (86.1)

 

14 (7.0)

 

179 (89.1)

 

Age group (year)

       

   20–30

107

92 (86.0)

0.972

5 (4.7)

0.683

95 (88.8)

0.156

   31–40

140

113 (80.7)

 

8 (5.7)

 

125 (89.3)

 

   41–50

112

93 (83.0)

 

6 (5.4)

 

88 (78.6)

 

   51–60

33

25 (75.8)

 

4 (12.1)

 

28 (84.8)

 

Nationality

       

   Saudi

108

84 (77.8)

0.027

7 (6.5)

0.680

90 (83.3)

0.104

   Non-Saudi

284

239 (84.2)

 

16 (5.6)

 

246 (86.6)

 

Experience in year

       

   1–10

183

154 (84.2)

0.903

8 (4.4)

0.108

164 (89.6)

0.149

   11–20

163

133 (81.6)

 

14 (8.6)

 

132 (81.0)

 

   21 or more

46

36 (78.3)

 

1 (2.2)

 

40 (87.0)

 

Degree

       

   Diploma

137

111 (81.0)

0.011

8 (5.8)

0.204

110 (80.3)

0.088

   Bachelor

130

116 (89.2)

 

8 (6.2)

 

117 (90.0)

 

   Master/high diploma

72

60 (83.3)

 

2 (2.8)

 

60 (83.3)

 

   Doctorate/Board

53

36 (67.9)

 

5 (9.4)

 

49 (92.5)

 

Position

       

   Consultant

21

16 (76.2)

0.500

3 (14.3)

0.351

19 (90.5)

0.810

   Specialist

69

54 (78.3)

 

3 (4.3)

 

62 (89.9)

 

   Resident

57

46 (80.7)

 

1 (1.8)

 

46 (80.7)

 

   General practitioner

30

23 (76.7)

 

2 (6.7)

 

24 (80.0)

 

   Head nurse

23

16 (69.6)

 

2 (8.7)

 

18 (78.3)

 

   Nurse

192

168 (87.5)

 

12 (6.3)

 

167 (87.0)

 

Original work place

       

   Makkah

164

136 (82.9)

0.574

12 (7.3)

0.651

136 (82.9)

0.643

   Riyadh

85

75 (88.2)

 

2 (2.4)

 

73 (85.9)

 

   North region

4

2 (50.0)

 

0

 

2 (50.0)

 

   Eastern region

53

45 (84.9)

 

4 (7.5)

 

49 (92.5)

 

   Jazan

8

6 (75.0)

 

0

 

8 (100.0)

 

   Asir

28

21 (75.0)

 

1 (3.6)

 

24 (85.7)

 

   Najran

13

12 (92.3)

 

2 (15.4)

 

13 (100.0)

 

   Baha

8

8 (100.0)

 

0

 

4 (50.0)

 

   Qaseem

21

14 (66.7)

 

2 (9.5)

 

19 (90.5)

 

   Aljouf

4

2 (50.0)

 

0

 

4 (100.0)

 

   Hail

4

2 (50.0)

 

0

 

4 (100.0)

 

Discussion

Until year 2000, bivalent (AC) meningococcal vaccination was recommended for all people coming to the Hajj areas from inside or outside Saudi Arabia. Since 2000, Neisseria meningitides W135 caused outbreaks among pilgrims for the first time in history [3]. As a result, since year 2000, the quadrivalent (ACWY135) meningococcal vaccination has been recommended by the Ministry of Health for all people coming for Hajj with revaccination every 3 years if the unconjugated polysaccharide vaccine was used. The quadrivalent meningococcal polysaccharide vaccine has been made available free of charge in all health care facilities for all HCWs as well as for other people within Saudi Arabia intending to perform Hajj. This study showed that compliance of HCWs with this vaccine was suboptimal (82.4%) with almost one fifth of HCWs being unvaccinated. Non-Saudi HCWs were significantly more compliant with this vaccine than Saudi HCWs. Further studies are needed to determine the reasons for the lower compliance among the Saudi HCWs. Possible explanations for this difference include better awareness of the importance of this vaccine among the non-Saudis and false sense of security and perceived low likelihood of contracting meningococcal meningitis among Saudi HCWs. Gender, age, years of experience, qualification degree, position, and original place of work were not significant predictors of compliance to the meningococcal vaccine.

During community influenza outbreaks, admitting patients infected with influenza to hospitals has led to nosocomial transmission of the disease, including transmission from staff to patients [46]. Transmission of influenza among medical staff causes absenteeism and considerable disruption of health care [710]. The Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP) in the United States recommend that all HCWs be vaccinated annually against influenza [11]. However, in spite of a long-standing recommendation for influenza vaccination of HCWs, and the availability of a safe and effective vaccine, influenza vaccination coverage levels among HCWs remain substantially low worldwide [11]. For instance, during 1989–2003, HCWs influenza vaccination coverage levels in the United States increased from 10% to 40%; however, coverage levels have remained relatively constant since 1997 [12]. Substantially lower vaccination rates have been reported among HCWs who have contact with certain populations at high risk in the United States [1316]. Low influenza vaccination coverage rates have also been reported from Europe [1720]. This vaccine is particularly recommended for HCWs working in Hajj because of the very high risk of acquiring influenza infection in such overcrowded situations. However, in this study, only 5.9% of HCWs received the current year's influenza virus vaccine. Gender, age, nationality, years of experience, qualification degree, position, and original place of work were not significant predictors of compliance to this vaccine. Reported barriers to HCWs receipt or acceptance of influenza vaccination include fear of vaccine side effects, insufficient time or inconvenience, perceived ineffectiveness of the vaccine, medical contraindication, perceived low likelihood of contracting influenza, reliance on treatment with homeopathic medications, avoidance of medications, and fear of needles [11].

Hepatitis B virus (HBV) infection is a major infectious hazard for HCWs [11, 12]. In general, the seroprevalence of HBV among HCWs is twofold to fourfold higher than that of blood donor controls [23]. The risk for acquiring HBV infection from occupational exposures is dependent on the frequency of percutaneous and permucosal exposures to blood or body fluids containing blood [22]. The risk for transmission from a single needlestick varies according to hepatitis B e antigen status: 1% to 6% for e antigen-negative blood compared with 22% to 40% with e antigen-positive blood [23]. Not all cases of HBV transmission are explained by needlesticks, suggesting that other modes of spread may be possible [23]. HBV vaccination of all HCWs has been strongly recommended [2]. The HBV three-dose vaccine series is 88% effective [24, 25]. From 1985 to 1994, the use of HBV vaccine and adherence to other preventive measures such as standard precautions lead to a 90% decline of HBV infection among HCWs in the United States [26, 27]. Even though, HBV vaccination of all HCWs has been strongly recommended, the vaccination coverage level of HCWs remains suboptimal with many studies reporting rates between 40–86% [2835]. A recent study from Saudi Arabia reported an overall compliance rate of 71.6% (932/1302) among HCWs [36]. In that study the compliance rate was 79.5% (492/619) among nurses, 78.3% (242/309) among technicians, and 52.9% (198/374) among physicians [36]. In the current study, the compliance rate was similar to earlier reports as only 66.3% of HCWs received the three-dose vaccine series, 19.3% received one or two doses, and 14.3% did not receive any dose. Gender, age, nationality, years of experience, qualification degree, position, and original place of work were not significant predictors of compliance to this vaccine.

Several strategies for improving HCWs vaccination coverage have been recommended [11]. Successful HCWs vaccination programs are multifaceted and combine publicity and education to combat fears and misconceptions about vaccines, use of reminder recall systems, efforts to remove administrative and financial barriers, role modeling, and monitoring and feedback on vaccination coverage [11]. Educational programs should emphasize the benefits of HCWs vaccination for staff and patients [11]. Organized campaigns that promote and make vaccine accessible can improve vaccination rates among HCWs [11]. Vaccination of senior medical staff or opinion leaders has been associated with higher vaccination acceptance among staff members under their leadership [11]. Removing administrative barriers such as costs and providing vaccine in locations and at times easily accessible by HCWs can substantially improve vaccine acceptance[11]. Making vaccine readily accessible at congregate areas (e.g., clinics), during conferences, or by use of mobile carts has been demonstrated to improve vaccination coverage rates [11]. Monitoring vaccination coverage by facility area (e.g., ward or unit) or occupational group allows facilities to identify where vaccination levels are low and interventions that should be targeted. Obtaining declination statements from HCWs who refuse vaccination for reasons other than medical contraindications can assist facilities in identifying personnel who might require targeted education or other interventions to overcome barriers to vaccine acceptance. In addition, collection of such information will allow health-care facilities to determine what proportion of their staff are reached and offered vaccine [11].

Conclusion

The meningococcal and hepatitis B vaccination coverage level among HCWs in Hajj was suboptimal and the influenza vaccination rate was notably low. Recommended strategies to improve vaccination coverage among HCWs should be adopted by all health care facilities in Saudi Arabia to ensure adequate vaccination coverage particularly with the Hajj-related vaccines.

Declarations

Authors’ Affiliations

(1)
Department of Medicine, Faculty of Medicine, King Abdulaziz University
(2)
The Ministry of Health
(3)
Department of Family and Community Medicine, Faculty of Medicine, King Abdulaziz University

References

  1. Bolyard EA, Tablan OC, Williams WW, Pearson ML, Shapiro CN, Deitchmann SD: Guideline for infection control in health care personnel, 1998. AJIC. 1998, 26: 289-354.Google Scholar
  2. Centers for Disease Control and Prevention: Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR. 1997, 46 (RR-18): 1-42.Google Scholar
  3. Al-Mazrou YY, Al-Jeffri MH, Abdalla MN, Elgizouli SA, Mishskas AA: Changes in epidemiological pattern of Meningococcal disease in Saudi Arabia; Does it constitute a new challenge for prevention and control?. Saudi Med J. 2004, 25: 1410-1413.PubMedGoogle Scholar
  4. Balkovic ES, Goodman RA, Rose FB, Borel CO: Nosocomial influenza A(H1N1) infection. Am J Med Technol. 1980, 46: 318-320.PubMedGoogle Scholar
  5. Van Voris LP, Belshe RB, Shaffer JL: Nosocomial influenza B virus infection in the elderly. Ann Intern Med. 1982, 96: 153-158.View ArticlePubMedGoogle Scholar
  6. Centers for Disease Control and Prevention: Suspected nosocomial influenza cases in an intensive care unit. MMWR. 1988, 37: 3-Google Scholar
  7. Pachucki CT, Walsh Pappas SA, Fuller GF, Krause SL, Lentino JR, Schaaf DM: Influenza A among hospital personnel and patients: implications for recognition, prevention, and control. Arch Intern Med. 1990, 149: 77-80. 10.1001/archinte.149.1.77.View ArticleGoogle Scholar
  8. Hammond GW, Cheang M: Absenteeism among hospital staff during an influenza epidemic: Implications for immunoprophylaxis. Can Med Assoc J. 1984, 131: 449-452.PubMedPubMed CentralGoogle Scholar
  9. Williams WW, Preblud SR, Reichelderfer PS, Hadler SC: Vaccines of importance in the hospital setting. Infect Dis Clin North Am. 1989, 3: 701-722.PubMedGoogle Scholar
  10. Mast EE, Harmon MW, Gravenstein S, Wu SP, Arden NH, Circo R, Tyszka G, Kendal AP, Davis JP: Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza (AH3N2). Am J Epidemiol. 1991, 134: 986-997.Google Scholar
  11. Pearson ML, Bridges CB, Harper SA, Healthcare Infection Control Practices Advisory Committee (HICPAC); Advisory Committee on Immunization Practices (ACIP): Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006, 55 (RR-2): 1-16.PubMedGoogle Scholar
  12. Centers for Disease Control and Prevention: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2005, 54 (RR-8): 1-40.
  13. Coles FB, Balzano GJ, Morse DL: An outbreak of influenza A (H3N2) in a well immunized nursing home population. J Am Geriatr Soc. 1989, 40: 589-592.View ArticleGoogle Scholar
  14. Bryant KA, Stover B, Cain L, Levine GL, Siegel J, Jarvis WR: Improving influenza immunization rates among healthcare workers caring for high-risk pediatric patients. Infect Control Hosp Epidemiol. 2004, 25: 912-917. 10.1086/502319.View ArticlePubMedGoogle Scholar
  15. Ikeda RM, Drabkin PD: Influenza A outbreaks in nursing homes [Comment]. J Am Geriatr Soc. 1992, 40: 1288-View ArticlePubMedGoogle Scholar
  16. Odelin MF, Pozzetto B, Aymard M, Defayolle M, Jolly-Million J: Role of influenza vaccination in the elderly during an epidemic of A/H1N1 virus in 1988–1989: clinical and serological data. Gerontology. 1993, 39: 109-116.View ArticlePubMedGoogle Scholar
  17. Szucs TD, Muller D: Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine. 2005, 23: 5055-5063. 10.1016/j.vaccine.2005.06.005.View ArticlePubMedGoogle Scholar
  18. Sartor C, Tissot-Dupont H, Zandotti C, Martin F, Roques P, Drancourt M: Use of a mobile cart influenza program for vaccination of hospital employees. Infect Control Hosp Epidemiol. 2004, 25: 918-922. 10.1086/502320.View ArticlePubMedGoogle Scholar
  19. Elorza Ricart JM, Campins Marti M, Martinez Gomez X, Allepuz Palau A, Ferrer Gramunt E, Mendez-Aguirre Guitian M: Influenza vaccine and health-care workers: strategies to achieve compliance in a tertiary hospital. Med Clin (Barc). 2002, 119: 451-452.View ArticleGoogle Scholar
  20. Harbarth S, Siegrist CA, Schira JC, Wunderli W, Pittet D: Influenza immunization: improving compliance of healthcare workers. Infect Control Hosp Epidemiol. 1998, 19: 337-342.View ArticlePubMedGoogle Scholar
  21. Centers for Disease Control and Prevention: Hepatitis surveillance report No. 56. 1996, Atlanta: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, 1-33.Google Scholar
  22. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 1997, 46 (RR-18): 1-42.
  23. Sepkowitz KA: Occupationally acquired infections in health care workers. Part II. Ann Intern Med. 1996, 125: 917-928.View ArticlePubMedGoogle Scholar
  24. Roome AJ, Watsh SJ, Cartter ML, Hadler JL: Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA. 1993, 270: 2931-2934. 10.1001/jama.270.24.2931.View ArticlePubMedGoogle Scholar
  25. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT: Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA. 1993, 270: 2935-2939. 10.1001/jama.270.24.2935.View ArticlePubMedGoogle Scholar
  26. Shapiro CN: Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am. 1995, 75: 1047-1056.View ArticlePubMedGoogle Scholar
  27. Lanphear BP, Linnemann CC, Cannon CG, DeRonde MM: Decline of clinical hepatitis B in workers at a general hospital: relation to increasing vaccine-induced immunity. Clin Infect Dis. 1993, 16: 10-14.View ArticlePubMedGoogle Scholar
  28. Ali NS, Jamal K, Qureshi R: Hepatitis B vaccination status and identification of risk factors for hepatitis B in health care workers. J Coll Physicians Surg Pak. 2005, 15: 257-260.PubMedGoogle Scholar
  29. Rachiotis G, Goritsas C, Alikakou V, Ferti A, Roumeliotou A: Vaccination against hepatitis B virus in workers of a general hospital in Athens. Med Lav. 2005, 96: 80-86.PubMedGoogle Scholar
  30. Duseja A, Arora L, Masih B, Singh H, Gupta A, Behera D, Chawla YK, Dhiman RK: Hepatitis B and C virus–prevalence and prevention in health care workers. Trop Gastroenterol. 2002, 23: 125-126.PubMedGoogle Scholar
  31. Fatusi OA, Esimai AO, Onayade AA, Ojo OS: Acceptance of hepatitis B vaccine by workers in a Nigerian teaching hospital. East Afr Med J. 2000, 77: 608-612.PubMedGoogle Scholar
  32. Smith ER, Banatvala JE, Tilzey AJ: Hepatitis B vaccine uptake among surgeons at a London teaching hospital: how well are we doing?. Ann R Coll Surg Engl. 1996, 78: 447-449.PubMedPubMed CentralGoogle Scholar
  33. Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E, Quinn TC: Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med. 1993, 153: 1705-1712. 10.1001/archinte.153.14.1705.View ArticlePubMedGoogle Scholar
  34. McKenzie C: Hepatitis B vaccination: a survey of health care workers' knowledge and acceptance. AAOHN J. 1992, 40: 517-520.PubMedGoogle Scholar
  35. Occupational infection among anaesthetists [Editorial]. Lancet. 1990, 336: 1103-10.1016/0140-6736(90)92577-5.
  36. Panhotra BR, Saxena AK, Al-Hamrani HA, Al-Mulhim A: Compliance to hepatitis B vaccination and subsequent development of seroprotection among health care workers of a tertiary care center of Saudi Arabia. Am J Infect Control. 2005, 33: 144-150. 10.1016/j.ajic.2005.01.002.View ArticlePubMedGoogle Scholar
  37. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/7/80/prepub

Copyright

© Madani and Ghabrah; licensee BioMed Central Ltd. 2007

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement